Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VEEV 
Veeva Systems Inc Class A (VEEV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/03/2025: VEEV (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
32 Analysts rated it
Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.
1 Year Target Price $315.17
1 Year Target Price $315.17
| 12 | Strong Buy |
| 7 | Buy |
| 11 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -20.19% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/03/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 39.67B USD | Price to earnings Ratio 46.77 | 1Y Target Price 315.17 |
Price to earnings Ratio 46.77 | 1Y Target Price 315.17 | ||
Volume (30-day avg) 32 | Beta 1.04 | 52 Weeks Range 201.54 - 310.50 | Updated Date 12/3/2025 |
52 Weeks Range 201.54 - 310.50 | Updated Date 12/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 5.16 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-20 | When After Market | Estimate 1.95 | Actual 2.04 |
Profitability
Profit Margin 27.93% | Operating Margin (TTM) 29.69% |
Management Effectiveness
Return on Assets (TTM) 7.64% | Return on Equity (TTM) 13.72% |
Valuation
Trailing PE 46.77 | Forward PE 27.93 | Enterprise Value 33122768067 | Price to Sales(TTM) 12.88 |
Enterprise Value 33122768067 | Price to Sales(TTM) 12.88 | ||
Enterprise Value to Revenue 10.75 | Enterprise Value to EBITDA 36.86 | Shares Outstanding 164381855 | Shares Floating 150895968 |
Shares Outstanding 164381855 | Shares Floating 150895968 | ||
Percent Insiders 8.49 | Percent Institutions 90.46 |
Upturn AI SWOT
Veeva Systems Inc Class A
Company Overview
History and Background
Veeva Systems was founded in 2007 by Peter Gassner and Matt Wallach. It focuses on cloud-based software solutions for the global life sciences industry. Veeva quickly became a leading provider of CRM and content management solutions tailored for pharmaceutical and biotechnology companies, evolving to offer a broader suite of applications.
Core Business Areas
- Veeva Commercial Cloud: Provides CRM, content management, and digital engagement solutions for sales and marketing teams in the life sciences industry.
- Veeva Vault: A cloud-based platform for managing content and data across the product lifecycle, including research and development, regulatory affairs, quality, and manufacturing.
- Veeva Business Consulting: Offers strategic consulting services to help life sciences companies optimize their business processes and implement Veeva's solutions effectively.
Leadership and Structure
Peter Gassner is the CEO. Veeva operates with a functional organizational structure, emphasizing specialization and expertise within specific departments. It has a well-defined management team overseeing various aspects of its business.
Top Products and Market Share
Key Offerings
- Veeva CRM: A CRM solution designed for life sciences companies, providing sales force automation, account management, and reporting capabilities. Veeva CRM dominates the pharma CRM market. Competitors include Salesforce and Microsoft Dynamics 365, but Veeva's industry-specific focus gives it a significant edge. Market share estimated 45% of Pharma CRM market. No direct revenue information is publicly reported.
- Veeva Vault EDC: A cloud-based electronic data capture (EDC) system for clinical trials. Veeva Vault EDC helps streamline data collection and management in clinical research. Competitors include Medidata Solutions (Dassault Systu00e8mes) and Oracle Clinical One. Market share estimated at 15% in a fragmented eClinical market. No direct revenue information is publicly reported.
- Veeva Vault CDMS: A suite of clinical data management applications on the Veeva Vault platform. Competitors include Medidata Solutions and Oracle Health Sciences. No market share data available as of October 2024. No direct revenue information is publicly reported.
Market Dynamics
Industry Overview
The life sciences industry is undergoing digital transformation, driving demand for cloud-based software solutions. Increased regulatory scrutiny and the need for efficient data management are key trends. High R&D spending and stringent compliance requirements characterize the industry.
Positioning
Veeva is a leader in cloud-based solutions for the life sciences industry. Its competitive advantages include its deep industry expertise, comprehensive product portfolio, and strong customer relationships.
Total Addressable Market (TAM)
Estimates put the total addressable market for Veeva at $20+ billion. Veeva is well-positioned to capture a significant portion of this market given its established presence and expanding product offerings.
Upturn SWOT Analysis
Strengths
- Strong brand reputation in the life sciences industry
- Comprehensive product portfolio covering multiple functional areas
- High customer retention rates
- Cloud-native architecture providing scalability and flexibility
- Deep industry expertise
Weaknesses
- Reliance on the life sciences industry makes it vulnerable to sector-specific downturns
- Higher price point compared to some competitors
- Integration challenges with legacy systems can be complex
Opportunities
- Expanding into new geographic markets
- Developing new products and services to address unmet needs in the life sciences industry
- Acquiring complementary businesses to broaden its product portfolio
- Leveraging AI and machine learning to enhance its solutions
Threats
- Increased competition from established software vendors and new entrants
- Changes in regulatory requirements impacting the life sciences industry
- Economic slowdowns affecting pharmaceutical spending
- Data security and privacy concerns
Competitors and Market Share
Key Competitors
- CRM (SALESFORCE), CDMS (ORCL), MDSO (Dassault Systu00e8mes)
Competitive Landscape
Veeva's competitive advantage lies in its industry-specific focus and comprehensive product portfolio. It faces competition from both established software vendors and specialized players.
Major Acquisitions
Crossix Solutions
- Year: 2019
- Acquisition Price (USD millions): 520
- Strategic Rationale: Enhance commercial cloud with data and analytics capabilities.
Physician World
- Year: 2021
- Acquisition Price (USD millions): 130
- Strategic Rationale: Increase remote pharmaceutical sales capabilities.
Growth Trajectory and Initiatives
Historical Growth: Veeva has demonstrated strong historical growth, driven by increasing adoption of its cloud-based solutions in the life sciences industry.
Future Projections: Analyst estimates suggest continued growth for Veeva, driven by expansion into new markets and product innovation.
Recent Initiatives: Recent initiatives include expanding its Vault platform capabilities and strategic acquisitions to broaden its product portfolio.
Summary
Veeva Systems is a strong player in the life sciences software industry, benefiting from its specialized focus and comprehensive product offerings. Its high customer retention and cloud-native architecture are key strengths. The company needs to watch out for increasing competition and economic shifts within the pharmaceutical sector. By expanding its markets and continued investment in innovation, they can continue growing.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings, Analyst reports, Industry publications, Financial news sources
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share estimates are based on available data and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Veeva Systems Inc Class A
Exchange NYSE | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 2013-10-16 | Founder, CEO & Director Mr. Peter P. Gassner | ||
Sector Healthcare | Industry Health Information Services | Full time employees 7291 | Website https://www.veeva.com |
Full time employees 7291 | Website https://www.veeva.com | ||
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud consisting of Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; and Veeva RIM that provides regulatory information management capabilities; as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.